Screener
Twist Bioscience Corporation TWST Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | Three months ended March 31, 2026 | Three months ended March 31, 2025 | Six months ended March 31, 2026 | Six months ended March 31, 2025 |
|---|---|---|---|---|
| Total costs and expenses | $156,578 | $134,353 | $293,176 | $257,711 |
| Loss from operations | $(45,863) | $(41,560) | $(78,763) | $(76,205) |
| Interest income | 1,710 | 2,801 | 3,885 | 6,041 |
| Other income (expense), net[1] | 175 | (394) | 646 | (487) |
| Loss before income taxes | $(43,978) | $(39,153) | $(74,232) | $(70,651) |
| Income tax expense | (43) | (175) | (296) | (271) |
| Net loss | $(44,021) | $(39,328) | $(74,528) | $(70,922) |
| Other comprehensive loss: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's other income, net (note 6)?
- Twist Bioscience Corporation (TWST) reported other income, net (note 6) of $175K in Q1 2026.
- How has Twist Bioscience Corporation's other income, net (note 6) changed year-over-year?
- Twist Bioscience Corporation's other income, net (note 6) increased by 144.4% year-over-year, from -$394K to $175K.
- What is the long-term trend for Twist Bioscience Corporation's other income, net (note 6)?
- Over 3 years (2021 to 2024), Twist Bioscience Corporation's other income, net (note 6) has grown at a 25.1% compound annual growth rate (CAGR), from -$1.37M to -$2.68M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Twist Bioscience Corporation's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude